ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $5.0M of Alnylam Pharmaceuticals, Inc.
Sold$5,005,421
$147.31Price
33,979Shares
−14%Stake
What ALNY did after the filing
- The stock from Mon, Mar 1 open, $149.36
- −8.8%
- S&P 500, same days
- +7.4%
Measured over 30 trading days, to the Apr 13 close.
Traded Thu, Feb 25. Filed Fri, Feb 26, 4:03 PM ET, after the close. Returns use the Mar 1 open and the Apr 13 close. Not investment advice.